SW480結腸がん細胞に対する葉酸機能化された共性有機フレームワークの抗がん効果:薬剤標的投与のための有望なツール
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。COF-FA@DOXという新しいナノキャリアは,大腸がんの治療のためにドクソルビシン (DOX) を効果的に提供します. この標的型アプローチは,癌細胞の吸収と細胞毒性を高め,移動と副作用を軽減します.
科学分野
- バイオマテリアル科学
- ナノテクノロジー
- ガン治療薬
背景
- 結腸直腸がんは治療に重大な課題を 抱えています
- 大腸がんの従来の治療には 限界があります
- 標的型薬剤投与システムは 有望な代替手段です
研究 の 目的
- ドクソルビシン (DOX) の標的投与のための新しいナノキャリア,COF-FA@DOXを開発し,特徴づけること.
- COF-FA@DOXナノキャリアの結腸直腸がん細胞に対するインビトロ抗癌効果を評価する.
主な方法
- COF-FA@DOXナノキャリアの合成と特徴付け
- SW480およびHUVEC細胞のMTT,フローサイトメトリー,スクラッチアッセイを含むインビトロアッセイ.
- 細胞吸収,細胞毒性,細胞サイクル,アポトーシス,および移動の評価
主要な成果
- COF-FA@DOXナノキャリアは,がん細胞による効率的な内部化を示しました.
- COF-FA@DOXの細胞毒性が,フリーDOXや他のナノキャリアと比較して,著しく増加した.
- COF- FA@ DOXは低用量では細胞サイクル停止,アポトーシス,細胞移動を阻害する.
結論
- COF-FA@DOXナノキャリアは,大腸がんにおけるドクソルビシンに対する有望な薬物投与システムです.
- 標的型投与は治療効果を高め,副作用を最小限に抑えることができます.
- 潜在的な臨床応用のために,さらなる in vivo 試験が必要である.
関連する概念動画
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...